Pacifico Biolabs specialises in the cultivation of microorganisms, focusing on developing ‘whole-muscle’ structures as sustainable and nutritious alternatives to traditional fish products.
Pacifico Biolabs has raised €10M across 2 funding rounds from 7 investors, most recently a Series A round in May 2026. Based in Berlin, Germany; active in Foodtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-27 | Series A | €7.0M | FoodLabs,regional brewery partner,Simon Capital,Sprout & About Ventures,Stray Dog Capital,Technologie Gründerfonds Sachsen (TGFS) | View deal → |
| 2024-02-16 | Pre-Seed | €3.1M | Exceptional Ventures,FoodLabs,Simon Capital,Sprout & About Ventures | View deal → |
